메뉴 건너뛰기




Volumn 6, Issue 3, 2006, Pages 327-334

In vivo induced antigen technology (IVIAT) and change mediated antigen technology (CMAT)

Author keywords

Bacterium; CMAT; DFI; IVET; IVIAT; Parasite; Pathogenesis; STM; Virulence

Indexed keywords

BACTERIAL STRAIN; BACTERIAL VIRULENCE; BCG VACCINATION; CHANGE MEDIATED ANTIGEN TECHNOLOGY; CLINICAL EFFECTIVENESS; CYSTIC FIBROSIS; DIAGNOSTIC TEST; DISEASE MODEL; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HUMAN; IN VIVO INDUCED ANTIGEN TECHNOLOGY; IN VIVO STUDY; LEISHMANIA; LEISHMANIASIS; MICROARRAY ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PERIODONTAL DISEASE; PSEUDOMONAS AERUGINOSA; RELIABILITY; REVIEW; SAFETY; SALMONELLA ENTERICA; SEROLOGY; STREPTOCOCCUS PYOGENES; TUBERCULOSIS; TYPHOID FEVER; VALIDATION PROCESS; WESTERN BLOTTING; XANTHOMONAS CAMPESTRIS; XYLELLA FASTIDIOSA;

EID: 33748668688     PISSN: 18715265     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152606778249908     Document Type: Review
Times cited : (5)

References (33)
  • 24
    • 0033517487 scopus 로고    scopus 로고
    • Herwaldt, B. L. Lancet 1999, 354, 1191-1199.
    • (1999) Lancet , vol.354 , pp. 1191-1199
    • Herwaldt, B.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.